Tag: inflammatory response

Audifort Update Reveals Breakthrough Botanical Formulation for Hearing Health Support in 2025

Plant-Based Daily Formula Updated in 2025 to Support Holistic Hearing Wellness and Lifestyle Resilience

Plant-Based Daily Formula Updated in 2025 to Support Holistic Hearing Wellness and Lifestyle Resilience

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability

TOMS RIVER, N.J., June 20, 2025 /PRNewswire/ -- In a supplement market saturated with empty promises and low-quality formulations, Pals Health emerges as a brand committed to...

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases.

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

Translational Data Presented at EACCI Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsInflammatory response

Alvopetro Announces June 2025 Sales Volumes

Oxford Business Group and Oman Investment Authority highlight sultanate’s economic transformation in new advisory report

Iridium Announces Release Date for Second-Quarter 2025 Financial Results

Tag: inflammatory response

Audifort Update Reveals Breakthrough Botanical Formulation for Hearing Health Support in 2025

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us